BMC Cancer

1. WU M, Gu S, Yang J, Zhao Y, et al
   Comprehensive machine learning-based preoperative blood features predict the prognosis for ovarian cancer.
   BMC Cancer. 2024;24:267.
   

   >> Share

   
   

   
   Curr Treat Options Oncol

2. ANBIL S, Reiss KA
   Targeting BRCA and PALB2 in Pancreatic Cancer.
   Curr Treat Options Oncol. 2024;25:346-363.
   

   >> Share

   
   

   
   Eur J Obstet Gynecol Reprod Biol

3. BRAUN C, Grunig H, Peikert J, Strobel K, et al
   Do PET-positive supradiaphragmatic lymph nodes predict overall survival or the success of primary surgery in patients with advanced ovarian cancer?
   Eur J Obstet Gynecol Reprod Biol. 2024;296:13-19.
   

   >> Share

   
   

   
   Gynecol Oncol

4. TAYLOR DD, Gercel-Taylor C, Parker LP
   Retraction notice to "Patient-derived tumor reactive antibodies as diagnostic markers for ovarian cancer" [Gynecologic Oncology 115 (2009) 112-120].
   Gynecol Oncol. 2024;181:186.
   

   >> Share

   
   
5. COSTALES AB, Crane EK, Chambers L, Yao M, et al
   Laparoscopic predictability of minimally invasive interval debulking in advanced ovarian cancer: The MIID-SOC trial.
   Gynecol Oncol. 2024;185:143-147.
   

   >> Share

   
   
6. RONCOLATO F, King MT, O'Connell RL, Lee YC, et al
   Hidden in plain sight - Survival consequences of baseline symptom burden in women with recurrent ovarian cancer.
   Gynecol Oncol. 2024;185:128-137.
   

   >> Share

   
   
7. VASTA FM, Cormio G, Cassani C, Bergamini A, et al
   Reproductive outcomes after conservative treatment in early and advanced stage MOGCTs.
   Gynecol Oncol. 2024;181:28-32.
   

   >> Share

   
   

   
   J Natl Cancer Inst

8. CAO A, Esserman DA, Cartmel B, Irwin ML, et al
   Association between diet quality and ovarian cancer risk and survival.
   J Natl Cancer Inst. 2024 Feb 23:djae040. doi: 10.1093.
   

   >> Share

   
   

   
   Lancet Oncol

9. MCPHAIL S, Barclay ME, Swann R, Johnson SA, et al
   Use of radiotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
   Lancet Oncol. 2024;25:352-365.
   

   >> Share

   
   
10. MCPHAIL S, Barclay ME, Johnson SA, Swann R, et al
    Use of chemotherapy in patients with oesophageal, stomach, colon, rectal, liver, pancreatic, lung, and ovarian cancer: an International Cancer Benchmarking Partnership (ICBP) population-based study.
    Lancet Oncol. 2024;25:338-351.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share